Biodistribution studies of protein cage nanoparticles demonstrate broad tissue distribution and rapid clearance in vivo
about
Stealth filaments: Polymer chain length and conformation affect the in vivo fate of PEGylated potato virus X.Virus-Based Nanoparticles as Versatile NanomachinesVirus-based nanomaterials as positron emission tomography and magnetic resonance contrast agents: from technology development to translational medicineEngineering of Brome mosaic virus for biomedical applicationsVirus-mimicking nano-constructs as a contrast agent for near infrared photoacoustic imaging.MRI-detectable nanoparticles: the potential role in the diagnosis of and therapy for chronic kidney disease.Transferrin-mediated targeting of bacteriophage HK97 nanoparticles into tumor cells.Increased tumor homing and tissue penetration of the filamentous plant viral nanoparticle Potato virus X.Infusion of imaging and therapeutic molecules into the plant virus-based carrier cowpea mosaic virus: cargo-loading and delivery.Supramolecular protein cage composite MR contrast agents with extremely efficient relaxivity properties.Endocytosis and exocytosis of nanoparticles in mammalian cells.Viral nanoparticles as platforms for next-generation therapeutics and imaging devicesBiodistribution and clearance of a filamentous plant virus in healthy and tumor-bearing mice.Viral nanoparticles as macromolecular devices for new therapeutic and pharmaceutical approaches.Protein cage nanoparticles bearing the LyP-1 peptide for enhanced imaging of macrophage-rich vascular lesions.Systemic delivery of protein nanocages bearing CTT peptides for enhanced imaging of MMP-2 expression in metastatic tumor modelsApplications of viral nanoparticles in medicine.Feasibility of Cowpea chlorotic mottle virus-like particles as scaffold for epitope presentations.Developing a Dissociative Nanocontainer for Peptide Drug Delivery.Virus-like particle-induced protection against MRSA pneumonia is dependent on IL-13 and enhancement of phagocyte function.Liver cell specific targeting by the preS1 domain of hepatitis B virus surface antigen displayed on protein nanocagesDevelopment of viral nanoparticles for efficient intracellular delivery.A virus-like particle vaccine platform elicits heightened and hastened local lung mucosal antibody production after a single dose.Design of virus-based nanomaterials for medicine, biotechnology, and energy.Inducible bronchus-associated lymphoid tissue (iBALT) synergizes with local lymph nodes during antiviral CD4+ T cell responses.Anti-atherogenic effect of trivalent chromium-loaded CPMV nanoparticles in human aortic smooth muscle cells under hyperglycemic conditions in vitro.Tobacco Mosaic Virus Delivery of Phenanthriplatin for Cancer therapy.Biodistribution, pharmacokinetics, and blood compatibility of native and PEGylated tobacco mosaic virus nano-rods and -spheres in miceTobacco mosaic virus-based protein nanoparticles and nanorods for chemotherapy delivery targeting breast cancer.CD11c⁺ cells primed with unrelated antigens facilitate an accelerated immune response to influenza virus in mice.Engineering hepatitis B virus core particles for targeting HER2 receptors in vitro and in vivo.Design rules for nanomedical engineering: from physical virology to the applications of virus-based materials in medicine.Using viruses as nanomedicines.Caged protein nanoparticles for drug delivery.Combination of Plant Virus Nanoparticle-Based in Situ Vaccination with Chemotherapy Potentiates Antitumor Response.Plant viruses and bacteriophages for drug delivery in medicine and biotechnology.Biomedical and Catalytic Opportunities of Virus-Like Particles in Nanotechnology.Nanocaged platforms: modification, drug delivery and nanotoxicity. Opening synthetic cages to release the tiger.Synthetic plant virology for nanobiotechnology and nanomedicineGuiding plant virus particles to integrin-displaying cells
P2860
Q27334548-151AD920-5146-4802-A464-1A3B44406B55Q28068538-1D832516-4E38-4BA4-81E1-B8AD448668BAQ28550482-9F470459-70D2-4DE6-8CC9-2CCF865D8D99Q28818683-554A9E7D-5CDE-4AAA-B8A5-5C9311815136Q30441972-D8269427-DDFD-421C-9CCC-D96D3AB8575EQ30457123-45449926-470A-4E90-821C-5D133D6FCA2EQ30500177-F21344D3-F275-4704-850F-05F065FBBA25Q30527772-9E0FC6CA-4375-4619-9EFB-F922FAAA58E6Q30556613-E5110D21-C32F-4792-B3AD-65E64B705754Q33514896-06E07981-3B42-4F6D-8182-8BD554351C6BQ33627669-8E7030C5-A05D-4826-A77C-2345A4E4684CQ34168677-203D2A12-4226-4636-9E6B-943EA04FA6B8Q34213499-47463B7C-D73C-4515-9DF2-0AC279C2B3AEQ34617331-A898E67C-7288-46EF-8A6E-E9A5698923CBQ34861181-EF31D518-4FE6-4CB3-B703-6DD916CC4B38Q35016398-53163B2B-6D4F-441E-8990-0AB393E3A144Q35501007-00723BCB-5F23-4A58-818B-4B8C34FC1BF1Q35756792-5129D1A7-6191-41A1-8E5B-75ED2D8DAD4AQ35810333-CA516242-D1B0-45C1-8D4C-2C06B564AC2BQ36071784-81FE8E27-5105-4279-AB74-0DD58A022E00Q36168987-217FDEBB-BF11-48A1-9DFE-6BC5ADFDF34EQ36583833-5C956039-23CC-4521-A6D5-E3D08795EC97Q36630332-6A569E36-4DBC-45B1-ACC8-1452C515DD84Q37346447-0FFAC9CC-0D06-4545-8FB6-861422321CB7Q37419245-00BBD01F-9299-4966-A36C-9CD3A45FF5B9Q37470658-982943CD-06E1-4C8F-B650-3B88C135144AQ37500884-FDA5739D-937C-4951-8B2F-F657E4D21DA8Q37531135-0FB3C330-695A-4115-97C0-009F9453BF10Q37551457-F07481A0-C6EA-4AD8-8929-9A0C34459A9DQ37588815-AFA80B45-8494-460B-A2B3-BE2C12CDB0B2Q37634520-B6873DBA-211D-448F-86D5-4638BCED22DBQ38122098-60CBC6F3-AC35-4AEF-B4AD-DA2CD1151EA0Q38191282-5FA6573D-7308-4441-BE69-9548E208DDC6Q38212056-EFCB3923-73EB-4A5C-83A7-64B58C666ABEQ38708960-AEB3C8E8-0780-4542-BAA8-61B3802CC661Q38828420-24411650-9C02-4B4B-8668-AA52F0EA82CFQ39068831-B235F74F-D83C-4EBD-AA11-4C491E809D01Q39076542-76FC2381-B2D3-413E-AD8F-AC6A1F3982CEQ39081725-577F1742-66E3-4699-A4F9-B951CFB74DDDQ39348354-B2F8F9FC-CB67-4D68-9E80-991891AD6DB7
P2860
Biodistribution studies of protein cage nanoparticles demonstrate broad tissue distribution and rapid clearance in vivo
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Biodistribution studies of pro ...... on and rapid clearance in vivo
@en
Biodistribution studies of pro ...... n and rapid clearance in vivo.
@nl
type
label
Biodistribution studies of pro ...... on and rapid clearance in vivo
@en
Biodistribution studies of pro ...... n and rapid clearance in vivo.
@nl
prefLabel
Biodistribution studies of pro ...... on and rapid clearance in vivo
@en
Biodistribution studies of pro ...... n and rapid clearance in vivo.
@nl
P2093
P2860
P1476
Biodistribution studies of pro ...... on and rapid clearance in vivo
@en
P2093
Allen G Harmsen
Ann L Harmsen
Coleen R Kaiser
Eric Gillitzer
Mark A Jutila
Mark J Young
Michelle L Flenniken
Trevor Douglas
P2860
P304
P407
P577
2007-01-01T00:00:00Z